Tag: VXRT stock

Companies

What Has Been Going On With Vaxart Inc (NASDAQ: VXRT)?

Vaxart Inc (NASDAQ:VXRT) traded at $0.42 at close of the session on Friday, March 28 and made a downward move of -7.83% on its previous day’s price. Looking at the stock we see that its previous close was $0.46 and the beta (5Y monthly) reads

Finance

Vaxart Inc (NASDAQ: VXRT) Has Yet To Win Over Analysts?

Vaxart Inc (NASDAQ:VXRT) traded at $0.46 at close of the session on Monday, March 10 and made a downward move of -2.09% on its previous day’s price. Vaxart Inc has a market cap of $104.64 million and is expected to release its quarterly earnings report

Companies

The Future Of Vaxart Inc (NASDAQ: VXRT) In 2025

Vaxart Inc (NASDAQ:VXRT) price on Thursday, February 27, fall -5.85% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $0.49. A look at the stock’s price movement, the close in the last trading session was $0.52. Turning to

Finance

Vaxart Inc (NASDAQ: VXRT) Continues To Decline

Vaxart Inc (NASDAQ:VXRT) price closed higher on Friday, February 21, and jumping 1.21% above its previous close. A look at the daily price movement shows that the last close reads $0.70. Taking into account the 52-week price action we note that the stock hit a

NNOX Stock
Market Summary

Why shares of Vaxart Inc. (VXRT) are rising in premarket trading?

Vaxart, Inc. (Nasdaq: VXRT), a clinical-stage biotechnology company specializing in the discovery, development, and commercialization of oral recombinant vaccines, announced that its founder and chief scientific officer, Sean Tucker, will be giving a presentation at the upcoming World Vaccine Congress Washington on May 4-6, 2021.